Finance

Lists
TVTX:NASDAQ
Travere Therapeutics Inc
USD 56,66
-0,33%
(-0,19) 1D
2 Okt., 11:40:26 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TVTX...
Open
USD 57,21
High
USD 57,53
Low
USD 56,44
Mkt. cap
5,34 mjd
Avg. vol.
1,49 m
Volume
285,10 k
52-wk high
USD 68,73
52-wk low
USD 22,59
EPS
-USD 0,50
Beta
1,13
Shares outstanding
94,26 m
No. of employees
497
Open
USD 57,21
High
USD 57,53
Low
USD 56,44
Mkt. cap
5,34 mjd
Avg. vol.
1,49 m
Volume
285,10 k
52-wk high
USD 68,73
52-wk low
USD 22,59
EPS
-USD 0,50
Beta
1,13
Shares outstanding
94,26 m
No. of employees
497
News stories
From web sources and news partners
About Travere Therapeutics Inc
CEO-
Employees497
Founded2011
Headquarters-
Sector-
Websitetravere.com
Analyst ratings
Based on 12 analysts giving stock ratings to TVTX in the past 3 months
Strong buy
Buy
11
Hold
1
Sell
0
12-month forecast
Based on 12 Wall Street analysts offering 12 month price targets for TVTX in the last 3 months.
Highest
Current USD 56,66
USD 90,00 (+58,84%)
Average
USD 75,92 (+33,99%)
Lowest
USD 62,00 (+9,42%)
Analyst
Recommendation
Action
Price target
Projected
Date
Vamil Divan
Guggenheim
Buy
Reiterated
USD 89,00
+57,1%
09/23/2026
Jason Zemansky
Bank of America Securities
Buy
Maintained
USD 71,00
+25,3%
09/23/2026
Laura Chico
Wedbush
Buy
Maintained
USD 76,00
+34,1%
09/22/2026
Joseph Pantginis
H.C. Wainwright
Buy
Reiterated
USD 67,00
+18,2%
09/23/2026
Allison Bratzel
Piper Sandler
Buy
Maintained
USD 68,00
+20%
08/17/2026
Edward Nash
Canaccord Genuity
Buy
Maintained
USD 70,00
+23,5%
08/11/2026
Gavin Clark-Gartner
Evercore ISI
Buy
Maintained
USD 78,00
+37,7%
08/10/2026
Alex Thompson CFA
Stifel Nicolaus
Hold
Maintained
USD 62,00
+9,4%
08/09/2026
Anupam Rama
J.P. Morgan
Buy
Maintained
USD 90,00
+58,8%
08/06/2026
Mohit Bansal
Wells Fargo
Buy
Maintained
USD 80,00
+41,2%
08/06/2026
Yigal Nochomovitz
Citi
Buy
Maintained
USD 85,00
+50%
08/06/2026
Tyler Van Buren
TD Cowen
Buy
Reiterated
USD 75,00
+32,4%
08/04/2026
Unknown Analyst
Wells Fargo
Buy
Maintained
USD 50,00
-11,8%
05/06/2026
Unknown Analyst
Evercore ISI
Buy
Maintained
USD 52,00
-8,2%
05/05/2026
Prakhar Agrawal
Cantor Fitzgerald
Buy
Reiterated
-
-
02/20/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
164,86 m
129,69 m
127,20 m
169,58 m
Cost of goods sold
53,48 m
60,42 m
83,86 m
69,52 m
Cost of revenue
53,48 m
60,42 m
83,86 m
69,52 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
86,45 m
101,69 m
80,25 m
96,11 m
Operating expense
86,45 m
101,69 m
80,25 m
96,11 m
Total operating expenses
139,93 m
162,12 m
164,11 m
165,63 m
Operating income
24,93 m
-32,43 m
-36,92 m
3,95 m
Other non operating income
487,00 k
11,07 m
-91,00 k
-40,18 m
EBT including unusual items
25,71 m
-21,06 m
-36,72 m
-35,00 m
EBT excluding unusual items
25,71 m
-21,06 m
-36,72 m
-35,00 m
Income tax expense
8,00 k
921,00 k
-120,00 k
-204,00 k
Effective tax rate
0,03%
-4,37%
0,33%
0,58%
Other operating expenses
-
-
-
-
Net income
25,71 m
2,73 m
-37,10 m
-34,80 m
Net profit margin
15,59%
2,10%
-29,17%
-20,52%
Earnings per share
0,59
0,37
0,05
-0,10
Interest and investment income
3,05 m
2,59 m
2,58 m
3,36 m
Interest expense
-2,75 m
-2,30 m
-2,30 m
-2,13 m
Net interest expenses
296,00 k
296,00 k
284,00 k
1,22 m
Depreciation and amortization charges
-
-
-
-
EBITDA
40,72 m
-14,29 m
-11,70 m
8,19 m
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme